loading
Precedente Chiudi:
$7.48
Aprire:
$7.23
Volume 24 ore:
148.60K
Relative Volume:
0.32
Capitalizzazione di mercato:
$12.29M
Reddito:
-
Utile/perdita netta:
$-14.58M
Rapporto P/E:
-6.7391
EPS:
-1.15
Flusso di cassa netto:
$-9.80M
1 W Prestazione:
+81.07%
1M Prestazione:
+79.81%
6M Prestazione:
+9.37%
1 anno Prestazione:
-81.28%
Intervallo 1D:
Value
$6.80
$7.90
Intervallo di 1 settimana:
Value
$4.10
$8.34
Portata 52W:
Value
$3.80
$42.80

Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile

Name
Nome
Acurx Pharmaceuticals Inc
Name
Telefono
917-533-1469
Name
Indirizzo
259 LIBERTY AVENUE, STATEN ISLAND
Name
Dipendente
4
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-18
Name
Ultimi documenti SEC
Name
ACXP's Discussions on Twitter

Confronta ACXP con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ACXP
Acurx Pharmaceuticals Inc
7.752 11.85M 0 -14.58M -9.80M -1.15
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
406.99 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
472.31 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
551.43 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
809.14 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
330.74 35.16B 4.56B -176.77M 225.30M -1.7177

Acurx Pharmaceuticals Inc Borsa (ACXP) Ultime notizie

pulisher
08:56 AM

Will Acurx Pharmaceuticals Inc. stock split attract more investors2025 Price Targets & Weekly High Momentum Picks - newser.com

08:56 AM
pulisher
03:49 AM

Can Acurx Pharmaceuticals Inc. (3ZO) stock test all time highsJuly 2025 Closing Moves & Verified Momentum Stock Ideas - newser.com

03:49 AM
pulisher
01:17 AM

Quantitative breakdown of Acurx Pharmaceuticals Inc. recent moveTrade Exit Summary & Entry Point Confirmation Alerts - newser.com

01:17 AM
pulisher
01:06 AM

Multi factor analysis applied to Acurx Pharmaceuticals Inc.Weekly Volume Report & Low Risk Entry Point Tips - newser.com

01:06 AM
pulisher
Oct 12, 2025

Acurx Pharmaceuticals Inc.’s volatility index tracking explainedMarket Volume Summary & Weekly Momentum Stock Picks - newser.com

Oct 12, 2025
pulisher
Oct 11, 2025

New to The Street Broadcasts Tonight on Bloomberg Featuring Roadzen, Metaterra, NRx Pharma, Blackbarn NYC, and Humanitarian Travel Group - Myrtle Beach Sun News

Oct 11, 2025
pulisher
Oct 11, 2025

Acurx Pharmaceuticals (NASDAQ:ACXP) Raised to Hold at Wall Street Zen - Defense World

Oct 11, 2025
pulisher
Oct 10, 2025

How Acurx Pharmaceuticals Inc. (3ZO) stock reacts to fiscal policiesWeekly Profit Summary & Weekly High Conviction Trade Ideas - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Acurx Pharmaceuticals granted Australian patent for antibiotics - Investing.com Australia

Oct 09, 2025
pulisher
Oct 09, 2025

Acurx Pharmaceuticals granted Australian patent for antibiotics By Investing.com - Investing.com Nigeria

Oct 09, 2025
pulisher
Oct 09, 2025

Australian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors - Stock Titan

Oct 09, 2025
pulisher
Oct 09, 2025

Measuring Acurx Pharmaceuticals Inc.’s beta against major indicesJuly 2025 Levels & Verified Swing Trading Watchlist - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

What drives Acurx Pharmaceuticals Inc stock pricePrice-to-Earnings Ratio Insights & High Return Market Tips - earlytimes.in

Oct 08, 2025
pulisher
Oct 08, 2025

Pharma Boom: Acurx on the Rise - StocksToTrade

Oct 08, 2025
pulisher
Oct 08, 2025

ACXP’s Steady Climb: New Developments? - timothysykes.com

Oct 08, 2025
pulisher
Oct 08, 2025

90% Plunge to 1000% Upside? Acurx Pharmaceuticals (ACXP) Stock Sees EMA Boost & Bold Analyst Predictions - ts2.tech

Oct 08, 2025
pulisher
Oct 08, 2025

Why Confluent Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket - Benzinga

Oct 08, 2025
pulisher
Oct 06, 2025

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Resigns with New to The Street for Long-Form Interviews, National TV Commercials, Earned Media, and Accredited Investor Events - Corpus Christi Caller-Times

Oct 06, 2025
pulisher
Oct 06, 2025

Will breakout in Acurx Pharmaceuticals Inc. lead to full recoveryPortfolio Update Summary & Daily Technical Stock Forecast Reports - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Acurx Pharmaceuticals Inc Stock Analysis and ForecastInterest Rate Changes & Build Capital Safely - earlytimes.in

Oct 05, 2025
pulisher
Oct 05, 2025

How supply shortages influence Acurx Pharmaceuticals Inc. (3ZO) stockInsider Buying & Weekly Stock Performance Updates - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Acurx Pharmaceuticals Inc. stock trendline breakdownChart Signals & Long-Term Investment Growth Plans - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Why retail investors favor Acurx Pharmaceuticals Inc. stockPortfolio Gains Report & Reliable Breakout Stock Forecasts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Will Acurx Pharmaceuticals Inc. stock outperform Nasdaq indexJuly 2025 Spike Watch & Daily Chart Pattern Signal Reports - newser.com

Oct 05, 2025
pulisher
Oct 04, 2025

New to The Street to Broadcast Nationwide on Bloomberg Tonight at 6:30 PM EST - Sacramento Bee

Oct 04, 2025
pulisher
Oct 04, 2025

Acurx Pharmaceuticals (NASDAQ:ACXP) Lowered to Sell Rating by Wall Street Zen - Defense World

Oct 04, 2025
pulisher
Oct 03, 2025

Will Acurx Pharmaceuticals Inc. (3ZO) stock return to pre crash levels2025 Price Action Summary & Comprehensive Market Scan Insights - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Chart overlay techniques for tracking Acurx Pharmaceuticals Inc.2025 Support & Resistance & Consistent Profit Alerts - newser.com

Oct 03, 2025
pulisher
Oct 01, 2025

Acurx Pharmaceuticals stock maintains Buy rating at H.C. Wainwright By Investing.com - Investing.com Nigeria

Oct 01, 2025
pulisher
Oct 01, 2025

Acurx Pharmaceuticals stock maintains Buy rating at H.C. Wainwright - Investing.com

Oct 01, 2025
pulisher
Oct 01, 2025

EMA approves Acurx’s pediatric plan for C. difficile drug ibezapolstat By Investing.com - Investing.com Nigeria

Oct 01, 2025
pulisher
Oct 01, 2025

Acurx Pharmaceuticals (NASDAQ:ACXP) Given “Buy” Rating at HC Wainwright - Defense World

Oct 01, 2025
pulisher
Sep 30, 2025

H.C. Wainwright Maintains Acurx Pharmaceuticals(ACXP.US) With Buy Rating, Maintains Target Price $31 - 富途牛牛

Sep 30, 2025
pulisher
Sep 30, 2025

Promising Outlook for Acurx Pharmaceuticals: Buy Rating Driven by Regulatory Milestones and Clinical Success of Ibezapolstat - TipRanks

Sep 30, 2025
pulisher
Sep 30, 2025

EMA approves Acurx’s pediatric plan for C. difficile drug ibezapolstat - Investing.com

Sep 30, 2025
pulisher
Sep 30, 2025

Acurx Pharmaceuticals, Inc. Announces Positive Opinion from EMA on Pediatric Investigation Plan for Ibezapolstat Use in Children with C. Difficile Infection - MarketScreener

Sep 30, 2025
pulisher
Sep 30, 2025

DYAI Stock Analysis and ForecastVolume Profile Analysis & Start Investing With Free Smart Watchlists - earlytimes.in

Sep 30, 2025
pulisher
Sep 30, 2025

20,000 Children Affected Annually: Acurx's New Antibiotic Gets Key EMA Support for C. difficile Treatment - Stock Titan

Sep 30, 2025

Acurx Pharmaceuticals Inc Azioni (ACXP) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Acurx Pharmaceuticals Inc Azioni (ACXP) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Sailer Carl
Director
Jan 06 '25
Buy
1.01
24,631
25,000
137,183
LUCI DAVID P
President and CEO
Jan 06 '25
Buy
1.01
49,261
50,000
1,097,458
Donohue James J.
Director
Jan 06 '25
Buy
1.01
9,852
10,000
22,352
DELUCCIA ROBERT J
Director
Jan 06 '25
Buy
1.01
49,261
50,000
1,010,196
DEAN JACK H
Director
Jan 06 '25
Buy
1.01
9,852
10,000
21,776
$84.60
price up icon 0.95%
$22.86
price up icon 6.98%
$32.48
price up icon 2.23%
$102.23
price up icon 0.32%
$165.94
price up icon 2.27%
biotechnology ONC
$330.74
price up icon 3.34%
Capitalizzazione:     |  Volume (24 ore):